Agile Therapeutics, Inc. (AGRX)
OTCMKTS: AGRX · Delayed Price · USD
1.410
-0.010 (-0.70%)
Jul 2, 2024, 3:55 PM EDT - Market closed
Agile Therapeutics Stock Forecast
AGRX's stock price has decreased by -53.47% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Agile Therapeutics stock has a target of 12, which predicts an increase of 751.06% from the current stock price of 1.41.
Analyst Consensus: Buy
* Price targets were last updated on Jun 26, 2023.
Analyst Ratings
The average analyst rating for AGRX stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 18, 2024 |
Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $5 | Hold → Strong Buy | Upgrades | $5 | +254.61% | Sep 22, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +751.06% | Jun 26, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +751.06% | Jun 7, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $250 → $150 | Strong Buy | Maintains | $250 → $150 | +10,538.30% | Dec 30, 2022 |
Financial Forecast
Revenue This Year
37.58M
from 19.59M
Increased by 91.78%
Revenue Next Year
51.95M
from 37.58M
Increased by 38.26%
EPS This Year
0.80
from -6.71
EPS Next Year
1.12
from 0.80
Increased by 41.03%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 38.7M | 53.5M | 69.6M |
Avg | 37.6M | 52.0M | 67.6M |
Low | 36.1M | 49.9M | 65.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 97.4% | 42.3% | 34.0% |
Avg | 91.8% | 38.3% | 30.2% |
Low | 84.3% | 32.8% | 25.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | 0.82 | 1.16 | 2.07 |
Avg | 0.80 | 1.12 | 2.01 |
Low | 0.76 | 1.08 | 1.93 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | 45.2% | 84.4% |
Avg | - | 41.0% | 79.1% |
Low | - | 35.5% | 72.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.